To gain scientific mindshare for its proteomics technologies, PerkinElmer Life and Analytical Sciences has embarked on a collaborative genomic and proteomic Alzheimer’s study of brains donated by monks, priests and nuns.
The pilot study, jointly conducted with the Rush Alzheimer’s Disease Center and the Buck Institute, has been going on for several months.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.